MTA1 (metastasis associated 1) is a transcriptional coregulator that functions as an integral component of the nuclear remodeling and deacetylation complex (NuRD), regulating gene expression through histone deacetylation and chr14 remodeling 1. The protein localizes primarily to the nucleus and acts as a histone deacetylase, also functioning as a transcription factor that can increase GATA-element reporter expression by 10-20 fold 2. MTA1 serves as a stress response protein that is upregulated under various stress conditions including heat shock, hypoxia, and irradiation, helping cancer cells survive in stressful environments 3. Beyond its nuclear functions, MTA1 acts as a novel ATP synthase complex modulator by interacting with ATP synthase F1 subunit alpha (ATP5A), driving mitochondrial metabolism reprogramming and enhancing oxidative phosphorylation 4. MTA1 is consistently overexpressed across multiple human cancer types including breast, liver, colon, pancreatic, prostate, and esophageal cancers, with expression levels correlating strongly with cancer aggressiveness and metastatic potential 15. The protein promotes tumor cell invasion, proliferation, epithelial-to-mesenchymal transition, and bone metastasis through formation of transcriptional-repressive complexes that target genes involved in cell growth and invasion 26.